/Investor DB

Longwood Fund — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

AAVantgarde Bioaavantgarde.comSeries A · Jun 2023 · $65M

Co-investorsNeva Sgr.Sofinnova PartnersXGEN VentureAtlas VentureForbion

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Alcyone Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.